The New York Entrepreneur

: Abbott, FDA reach deal to resume making baby formula at U.S. plant amid shortage

Read Time:12 Second

Abbott Laboratories and the Food and Drug Administration reached a deal Monday to restart production of baby formula at a U.S. plant that has been shut down amid a recall of the product, which contributed to a nationwide shortage of formula.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post The Ratings Game: SoFi shares have taken too heavy a beating ahead of ‘significant earnings momentum,’ analyst says
Next post Best New Ideas in Retirement: ‘This is a daunting time to retire’: In the age of inflation, there are steps you can take to deal with higher prices